Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Fontana

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
European Urology Oncology|May 26, 2022
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority TrialAndrea Gallioli, Pietro Diana, Matteo Fontana, et al.
European Urology Focus|March 16, 2019
Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate in Patients Under Either Anticoagulation or Antiplatelet TherapyLuca Boeri, Paolo Capogrosso, Eugenio Ventimiglia, et al.
European Urology Focus|September 17, 2018
Impact of Surgical Experience on Radiation Exposure during Retrograde Intrarenal Surgery: A Propensity-Score Matching AnalysisLuca Boeri, Andrea Gallioli, Elisa De Lorenzis, et al.
Plos One|January 26, 2022
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysisGiulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Cancers|October 14, 2023
Penile-Sparing Surgery for Tumour Recurrence after Previous Glansectomy/Partial Penectomy: Treatment Feasibility and Oncological OutcomesGennaro Musi, Filippo Molinari, Francesco A Mistretta, et al.
Critical Care (London, England)|September 30, 2020
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilationFrancesco Menzella, Matteo Fontana, Carlo Salvarani, et al.
Neoplasma|July 27, 2023
What is the best time for postoperative radiation therapy in pN1 prostate cancer?Francesco Alessandro Mistretta, Stefano Luzzago, Giulia Marvaso, et al.
Urologic Oncology|April 25, 2025
Thermal ablation for local tumor recurrence after previous partial nephrectomy: Perioperative and oncological outcomesChiara Vaccaro, Francesco A Mistretta, Mattia Luca Piccinelli, et al.
Urology|December 13, 2023
Oncological Outcomes of Thulium-Yttrium-Aluminum-Garnet (Tm:YAG) Laser Ablation for Penile CancerGennaro Musi, Ottavio de Cobelli, Filippo Molinari, et al.
Urologic Oncology|May 21, 2023
Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over timeFrancesco A Mistretta, Stefano Luzzago, Sarah Alessi, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
European Urology Oncology|May 26, 2022
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority TrialAndrea Gallioli, Pietro Diana, Matteo Fontana, et al.
European Urology Focus|March 16, 2019
Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate in Patients Under Either Anticoagulation or Antiplatelet TherapyLuca Boeri, Paolo Capogrosso, Eugenio Ventimiglia, et al.
European Urology Focus|September 17, 2018
Impact of Surgical Experience on Radiation Exposure during Retrograde Intrarenal Surgery: A Propensity-Score Matching AnalysisLuca Boeri, Andrea Gallioli, Elisa De Lorenzis, et al.
Plos One|January 26, 2022
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysisGiulia Cassone, Giovanni Dolci, Giulia Besutti, et al.
Cancers|October 14, 2023
Penile-Sparing Surgery for Tumour Recurrence after Previous Glansectomy/Partial Penectomy: Treatment Feasibility and Oncological OutcomesGennaro Musi, Filippo Molinari, Francesco A Mistretta, et al.
Critical Care (London, England)|September 30, 2020
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilationFrancesco Menzella, Matteo Fontana, Carlo Salvarani, et al.
Neoplasma|July 27, 2023
What is the best time for postoperative radiation therapy in pN1 prostate cancer?Francesco Alessandro Mistretta, Stefano Luzzago, Giulia Marvaso, et al.
Urologic Oncology|April 25, 2025
Thermal ablation for local tumor recurrence after previous partial nephrectomy: Perioperative and oncological outcomesChiara Vaccaro, Francesco A Mistretta, Mattia Luca Piccinelli, et al.
Urology|December 13, 2023
Oncological Outcomes of Thulium-Yttrium-Aluminum-Garnet (Tm:YAG) Laser Ablation for Penile CancerGennaro Musi, Ottavio de Cobelli, Filippo Molinari, et al.
Urologic Oncology|May 21, 2023
Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over timeFrancesco A Mistretta, Stefano Luzzago, Sarah Alessi, et al.
Pageof 8